Krismeikesari Krismeikesari 2025. Comparative Efficacy and Safety of Individual SGLT2 Inhibitors (Dapagliflozin, Empagliflozin, and Canagliflozin) on Kidney Function Decline in CKD: A Systematic Review and Network Meta-Analysis. Open Access Indonesian Journal of Medical Reviews. 5, 6 (Nov. 2025), 1772-1789. DOI:https://doi.org/10.37275/oaijmr.v5i6.818.